Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice

Clinical and Experimental Immunology

Volumn 132, Issue 1, 2003, Pages 40-45

  Holáň, Vladimír ^a   Zajicova A ^a   Krulova M ^a   Blahoutova V ^a   Wilczek, H ^b  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cytokine production; Heroin; Naltrexone; Skin allografts; Tumour growth

Indexed keywords

ALLOANTIGEN; CYTOKINE; DIAMORPHINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MORPHINE; NALTREXONE; NITRIC OXIDE; OPIATE RECEPTOR;

ALLOTRANSPLANTATION; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG USE; GRAFT REJECTION; HEROIN DEPENDENCE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OPIATE ADDICTION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RECIPIENT; SKIN ALLOGRAFT; SPLEEN CELL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELLS, CULTURED; CYTOKINES; FEMALE; FIBROSARCOMA; HEROIN; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; RECEPTORS, OPIOID; SKIN TRANSPLANTATION; SPLEEN; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0347997292     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02103.x     Document Type: Article

References (33)

1. Pacifici R, Di Carlo S, Bacosi A, Pichini S, Zuccaro P. Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int J Immunopharmacol 2000; 22:603-14.
2. Pacifici R, Minetti M, Zuccaro P, Pietraforte D. Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release. Int J Immunopharmacol 1995; 17:771-7.
3. Peng X, Mosser DM, Adler MW, Rogers TJ, Meisser JJ, Eisenstein TK. Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages. J Leukoc Biol 2000; 68:723-8.
4. Nelson CJ, How T, Lysle DT. Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase. Clin Immunol 1999; 93:176-83.
5. Zubelewicz B, Braczkowski R, Renshaw D, Harbuz MS. Central injection of morphine stimulates plasma corticosterone and interleukin (IL) -6 and IL-6 R mRNAs in the pituitary and adrenals in adjuvant-induced arthritis. J Biol Regul Homeost Agents 1999; 13:103-9.
6. Houghtling RA, Mellon RD, Tan RJ, Bayer BM. Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels. Ann N Y Acad Sci 2000; 917:771-7.
7. Roy S, Cain KJ, Chapin RB, Charboneau RG, Barke RA. Morphine modulated NF kappa B activation in macrophages. Biochem Biophys Res Commun 1998; 245:392-6.
8. Kapasi AA, Gibbons N, Mattana J, Singhal PC. Morphine stimulates mesangial cell TNF-alfa and nitrite production. Inflammation 2000; 24:463-76.
9. Bayer BM, Gastonguay MR, Hernandez MC. Distinction between the in vitro and in vivo inhibiotory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 1992; 23:117-24.
10. Bryant HU, Bernton EW, Holaday JW. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci 1987; 41:1731-8.
11. Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 1993; 265:1071-8.
12. Krulová M, Zajícová A, Frič J, Holáň V. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice. Transpl Int 2002; 15:108-16.
13. + T cells. Transplantation 1999; 68:97-100.
14. Yamamoto M, Einaga-Naito K, Kuriyama M, Kawada Y, Yoshida R. Cellular basis of skin allograft rejecion. Specific lysis of allogeneic skin components by non-T cells. Transplantation 1998; 65:818-25.
15. Billingham RE, Brent L, Medawar PB. Quantitative studies on tissue transplantation immunity. The survival times of skin homografts exchanged between members of different inbred strains of mice. Proc Roy Soc Lond 1954; 143:43-55.
16. Bubeník J, Indrová M, Němečková Š et al. Solubilized tumour-associated antigens of methylcholanthrene-induced sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests. Int J Cancer 1987; 21:348-55.
17. Holáň V, Zajícová A, Krulová M, Plšková J, Frič J, Filipec M. Induction of specific transplantation immunity by oral immunization with allogeneic cells. Immunology 2000; 101:404-11.
18. + T cells. J Immunol 1998; 161:3237-41.
19. 15N]nitrate in biological fluids. Anal Biochem 1982; 126:131-8.
20. Govitrapong P, Suttitum T, Kotchabhakdi N, Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther 1998; 286:883-9.
21. Bhargava HN, Thomas PT, Thorat S, House RV. Effect of morphine tolerance and abstinence on cellular immune function. Brain Res 1994; 642:1-10.
22. MacFarlane AS, Peng X, Meissler JJ Jr et al. Morphine increases susceptibility to oral Salmonella typhimurium infection. J Infect Dis 2000; 181:1350-8.
23. Roy S, Barke RA, Loh HH. Mu-opioid receptor-knockout mice, role of mu-opioid receptor in morphine mediated immune functions. Mol Brain Res 1998; 61:190-4.
24. Carr DJ, Bost KL, Blalock JE. The production of antibodies which recognize opiate receptors on murine leukocytes. Life Sci 1988; 42:2615-24.
25. Houghtling RA, Bayer BM. Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland. J Pharmacol Exp Ther 2002; 300:213-9.
26. Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol 2002; 71:782-90.
27. House SD, Mao X, Wu G, Espinelli D, Li WX, Chang SL. Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic-pituitary-adrenal axis. J Neuroimmunol 2001; 118:277-85.
28. Zagon IS, McLaughlin PJ. Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma. Brain Res Bull 1981; 7:25-32.
29. Kim MH, Hahm TS. Plasma levels of interleukin-6 and interleukin-10 are affected by ketorolac as an adjunct to patient-controlled morphine after abdominal hysterectomy. Clin J Pain 2001; 17:72-7.
30. Nathan C. Natural resistance and nitric oxide. Cell 1995; 82:873-6.
31. Holáň V, Krulová M, Zajícová A, Pindjáková J. Nitric oxide as a regulatory and effector molecule in the immune system. Molec Immunol 2002; 38:989-95.
32. Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S. Morphine modulates lymph node-derived T lymphocyte function. role of caspase-3, -8, and nitric oxide. J Leukoc Biol 2001; 70:527-36.
33. Fecho K, Maslonek KA, Coussons-Read ME, Dykstra LA, Lysle DT. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J Immunol 1994; 152:1545-52.